SI2026832T1 - Kombinacija interferona beta in kladribinskega režima za zdravljenje multiple skleroze - Google Patents
Kombinacija interferona beta in kladribinskega režima za zdravljenje multiple sklerozeInfo
- Publication number
- SI2026832T1 SI2026832T1 SI200730939T SI200730939T SI2026832T1 SI 2026832 T1 SI2026832 T1 SI 2026832T1 SI 200730939 T SI200730939 T SI 200730939T SI 200730939 T SI200730939 T SI 200730939T SI 2026832 T1 SI2026832 T1 SI 2026832T1
- Authority
- SI
- Slovenia
- Prior art keywords
- multiple sclerosis
- interferon
- beta
- combination
- treating multiple
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06114537 | 2006-05-24 | ||
| US84547006P | 2006-09-18 | 2006-09-18 | |
| EP07729448A EP2026832B1 (en) | 2006-05-24 | 2007-05-23 | Combination of interferon-beta and a cladribine regimen for treating multiple sclerosis |
| PCT/EP2007/055013 WO2007135172A2 (en) | 2006-05-24 | 2007-05-23 | Cladribine regimen for treating multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2026832T1 true SI2026832T1 (sl) | 2012-07-31 |
Family
ID=37395884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200730939T SI2026832T1 (sl) | 2006-05-24 | 2007-05-23 | Kombinacija interferona beta in kladribinskega režima za zdravljenje multiple skleroze |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN101500598A (pt) |
| AT (1) | ATE555804T1 (pt) |
| BR (1) | BRPI0710326A2 (pt) |
| DK (1) | DK2026832T3 (pt) |
| EC (1) | ECSP088997A (pt) |
| ES (1) | ES2384399T3 (pt) |
| MY (1) | MY149042A (pt) |
| NZ (1) | NZ572680A (pt) |
| PT (1) | PT2026832E (pt) |
| RS (1) | RS52424B (pt) |
| SI (1) | SI2026832T1 (pt) |
| UA (1) | UA96941C2 (pt) |
-
2007
- 2007-05-23 UA UAA200813662A patent/UA96941C2/ru unknown
- 2007-05-23 RS RS20120252A patent/RS52424B/en unknown
- 2007-05-23 CN CNA2007800178290A patent/CN101500598A/zh active Pending
- 2007-05-23 SI SI200730939T patent/SI2026832T1/sl unknown
- 2007-05-23 MY MYPI20084741A patent/MY149042A/en unknown
- 2007-05-23 ES ES07729448T patent/ES2384399T3/es active Active
- 2007-05-23 AT AT07729448T patent/ATE555804T1/de active
- 2007-05-23 BR BRPI0710326-3A patent/BRPI0710326A2/pt not_active IP Right Cessation
- 2007-05-23 NZ NZ572680A patent/NZ572680A/en unknown
- 2007-05-23 DK DK07729448.6T patent/DK2026832T3/da active
- 2007-05-23 PT PT07729448T patent/PT2026832E/pt unknown
-
2008
- 2008-12-19 EC EC2008008997A patent/ECSP088997A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE555804T1 (de) | 2012-05-15 |
| UA96941C2 (ru) | 2011-12-26 |
| DK2026832T3 (da) | 2012-06-25 |
| RS52424B (en) | 2013-02-28 |
| CN101500598A (zh) | 2009-08-05 |
| BRPI0710326A2 (pt) | 2011-08-09 |
| NZ572680A (en) | 2011-11-25 |
| PT2026832E (pt) | 2012-06-01 |
| ECSP088997A (es) | 2009-01-30 |
| ES2384399T3 (es) | 2012-07-04 |
| MY149042A (en) | 2013-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007135172A3 (en) | Cladribine regimen for treating multiple sclerosis | |
| PH12014502847A1 (en) | Combination treatment (eg with abt-072-333) of daas for use in treating hcv | |
| PH12014502848A1 (en) | Methods for treating hcv comprising at least two direct acting antiviral agent, ribavirin but not interferon | |
| ZA200807879B (en) | Use of bifidobacterium longum for the prevention and treatment of inflammation | |
| MY162067A (en) | Combination therapy for treatment of patients with neurological disorders and cerebral infarction | |
| HK1142270A1 (en) | Silibinin component for the treatment of hepatitis | |
| PH12013501791A1 (en) | Uses of dpp~iv inhibitors | |
| UA106756C2 (uk) | Генетичні маркери, асоційовані з відповіддю на інтерферон-альфа | |
| TN2011000176A1 (en) | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug | |
| MX2008013304A (es) | Compuestos de peptido 1 tipo glucagon. | |
| TW200630105A (en) | Herbal composition PHY906 and its use in chemotherapy | |
| MX2014002555A (es) | Una composicion farmacéutica para tratar cáncer, que comprende un conjugado de interferón alfa. | |
| WO2012063134A3 (en) | Cardiac glycoside analogs in combination with emodin for cancer therapy | |
| NZ705124A (en) | Interferon-beta for use as monotherapy or in combination with other cancer therapies | |
| MX2009003532A (es) | Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina. | |
| IL205452A (en) | Interferon type I antagonists and their use in the preparation of scleroderma drugs | |
| SI2026832T1 (sl) | Kombinacija interferona beta in kladribinskega režima za zdravljenje multiple skleroze | |
| Fukumoto et al. | New hope for Nutlin-3a therapy for pulmonary arterial hypertension | |
| UA103907C2 (ru) | Терапевтический режим лечения гепатита, который включает пег-интерферон, рибавирин и vx-950 | |
| UA41629U (ru) | Способ лечения хронической токсоплазмозной инфекции | |
| UA66404U (ru) | Способ профилактики и лечения остеопороза у беременных с перинатальным инфицированием | |
| MY174803A (en) | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug | |
| UA99163C2 (ru) | Способ дозирования инъекционной формы палиперидона пальмитата продолжительного действия | |
| SG146498A1 (en) | Compositions for treatment of patients with neurological disorders and cerebral infarction | |
| UA50803U (ru) | Способ лечения острых инфекционных вирусных заболеваний у больных с хронической патологией органов пищеварения |